Back
Sarepta Therapeutics Vs. Nike Industry Stock Comparison
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
153.17
Seasonality Move:
21.71%
Sell
17
NKE
Nike
Last Price:
75.29
Seasonality Move:
6.25%
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $153.11. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $75.24. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $153.11
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
NKE Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.63 | Buy |
Relative Strength Index (14 RSI): | 63.2 | Buy |
Chaikin Money Flow: | -127791 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (116.89 - 152.23) | Buy |
Bollinger Bands (100): | (118.36 - 139.6) | Buy |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.95 | Sell |
Relative Strength Index (14 RSI): | 21.04 | Sell |
Chaikin Money Flow: | -8144437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (84.75 - 98.87) | Sell |
Bollinger Bands (100): | (89.12 - 101.24) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 157.31 | Sell |
20-day SMA: | 137.48 | Buy |
50-day SMA: | 131.86 | Buy |
200-day SMA: | 116.36 | Buy |
8-day EMA: | 152.45 | Buy |
20-day EMA: | 143.02 | Buy |
50-day EMA: | 134.19 | Buy |
200-day EMA: | 122.39 | Buy |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.46 | Sell |
20-day SMA: | 91.29 | Sell |
50-day SMA: | 92.23 | Sell |
200-day SMA: | 99.9 | Sell |
8-day EMA: | 82.83 | Sell |
20-day EMA: | 88.48 | Sell |
50-day EMA: | 91.81 | Sell |
200-day EMA: | 99.03 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
Sarepta Therapeutics Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |